Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Voriconazole for Invasive and Esophageal Candidiasis in Pediatric Subjects
NCT01092832Phase 3Terminated
- Sponsor
- Pfizer
- Start
- Oct 2010
- Primary completion
- May 2013
- Modality
- Orthosteric Ligands
- Countries
- 8
01
Overview
A Phase 3 trial of voriconazole in invasive candidiasis, candidemia, esophageal candidiasis, sponsored by Pfizer. Started Oct 2010; status: terminated.
02
Drugs
voriconazole
03
Conditions
invasive candidiasiscandidemiaesophageal candidiasis
Beyond the preview
Go deeper on NCT01092832.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01092832.